1. Home
  2. GNLN vs INTS Comparison

GNLN vs INTS Comparison

Compare GNLN & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLN
  • INTS
  • Stock Information
  • Founded
  • GNLN 2005
  • INTS 2012
  • Country
  • GNLN United States
  • INTS United States
  • Employees
  • GNLN N/A
  • INTS N/A
  • Industry
  • GNLN Durable Goods
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNLN Consumer Discretionary
  • INTS Health Care
  • Exchange
  • GNLN Nasdaq
  • INTS Nasdaq
  • Market Cap
  • GNLN 12.9M
  • INTS 12.2M
  • IPO Year
  • GNLN 2019
  • INTS 2023
  • Fundamental
  • Price
  • GNLN $2.97
  • INTS $0.46
  • Analyst Decision
  • GNLN
  • INTS Strong Buy
  • Analyst Count
  • GNLN 0
  • INTS 4
  • Target Price
  • GNLN N/A
  • INTS $4.50
  • AVG Volume (30 Days)
  • GNLN 750.7K
  • INTS 86.0M
  • Earning Date
  • GNLN 11-14-2025
  • INTS 11-07-2025
  • Dividend Yield
  • GNLN N/A
  • INTS N/A
  • EPS Growth
  • GNLN N/A
  • INTS N/A
  • EPS
  • GNLN N/A
  • INTS N/A
  • Revenue
  • GNLN $7,954,000.00
  • INTS N/A
  • Revenue This Year
  • GNLN $1,541.21
  • INTS N/A
  • Revenue Next Year
  • GNLN N/A
  • INTS N/A
  • P/E Ratio
  • GNLN N/A
  • INTS N/A
  • Revenue Growth
  • GNLN N/A
  • INTS N/A
  • 52 Week Low
  • GNLN $2.75
  • INTS $0.19
  • 52 Week High
  • GNLN $2,737.50
  • INTS $3.40
  • Technical
  • Relative Strength Index (RSI)
  • GNLN 36.35
  • INTS 51.38
  • Support Level
  • GNLN $3.06
  • INTS $0.52
  • Resistance Level
  • GNLN $3.29
  • INTS $0.63
  • Average True Range (ATR)
  • GNLN 0.25
  • INTS 0.16
  • MACD
  • GNLN -0.04
  • INTS 0.01
  • Stochastic Oscillator
  • GNLN 20.00
  • INTS 15.24

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: